» Articles » PMID: 37108107

Synaptic Targets of Glycinergic Neurons in Laminae I-III of the Spinal Dorsal Horn

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 28
PMID 37108107
Authors
Affiliations
Soon will be listed here.
Abstract

A great deal of evidence supports the inevitable importance of spinal glycinergic inhibition in the development of chronic pain conditions. However, it remains unclear how glycinergic neurons contribute to the formation of spinal neural circuits underlying pain-related information processing. Thus, we intended to explore the synaptic targets of spinal glycinergic neurons in the pain processing region (laminae I-III) of the spinal dorsal horn by combining transgenic technology with immunocytochemistry and in situ hybridization accompanied by light and electron microscopy. First, our results suggest that, in addition to neurons in laminae I-III, glycinergic neurons with cell bodies in lamina IV may contribute substantially to spinal pain processing. On the one hand, we show that glycine transporter 2 immunostained glycinergic axon terminals target almost all types of excitatory and inhibitory interneurons identified by their neuronal markers in laminae I-III. Thus, glycinergic postsynaptic inhibition, including glycinergic inhibition of inhibitory interneurons, must be a common functional mechanism of spinal pain processing. On the other hand, our results demonstrate that glycine transporter 2 containing axon terminals target only specific subsets of axon terminals in laminae I-III, including nonpeptidergic nociceptive C fibers binding IB4 and nonnociceptive myelinated A fibers immunoreactive for type 1 vesicular glutamate transporter, indicating that glycinergic presynaptic inhibition may be important for targeting functionally specific subpopulations of primary afferent inputs.

Citing Articles

Molecular Anatomy of Synaptic and Extrasynaptic Neurotransmission Between Nociceptive Primary Afferents and Spinal Dorsal Horn Neurons.

Antal M Int J Mol Sci. 2025; 26(5).

PMID: 40076973 PMC: 11900602. DOI: 10.3390/ijms26052356.


Impaired Presynaptic Function Contributes Significantly to the Pathology of Glycine Receptor Autoantibodies.

Wiessler A, Zheng F, Werner C, Habib M, Tuzun E, Alzheimer C Neurol Neuroimmunol Neuroinflamm. 2025; 12(2):e200364.

PMID: 39819053 PMC: 11741293. DOI: 10.1212/NXI.0000000000200364.

References
1.
Aubrey K, Supplisson S . Heterogeneous Signaling at GABA and Glycine Co-releasing Terminals. Front Synaptic Neurosci. 2018; 10:40. PMC: 6232519. DOI: 10.3389/fnsyn.2018.00040. View

2.
Todd A, Sullivan A . Light microscope study of the coexistence of GABA-like and glycine-like immunoreactivities in the spinal cord of the rat. J Comp Neurol. 1990; 296(3):496-505. DOI: 10.1002/cne.902960312. View

3.
Hughes D, Sikander S, Kinnon C, Boyle K, Watanabe M, Callister R . Morphological, neurochemical and electrophysiological features of parvalbumin-expressing cells: a likely source of axo-axonic inputs in the mouse spinal dorsal horn. J Physiol. 2012; 590(16):3927-51. PMC: 3476641. DOI: 10.1113/jphysiol.2012.235655. View

4.
Todd A . Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci. 2010; 11(12):823-36. PMC: 3277941. DOI: 10.1038/nrn2947. View

5.
Nunez E, Perez-Siles G, Rodenstein L, Alonso-Torres P, Zafra F, Jimenez E . Subcellular localization of the neuronal glycine transporter GLYT2 in brainstem. Traffic. 2009; 10(7):829-43. DOI: 10.1111/j.1600-0854.2009.00911.x. View